Author

Dimitrios Skaltsas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Vassilis G. GorgoulisiD· 2 shared Alexandros StratigosiD· 1 shared Andreas DimakakosiD· 1 shared Aristotelis TsirigosiD· 1 shared Dimitrios Christos TremoulisiD· 1 shared Dimitrios ValakosiD· 1 shared Dimitris KletsasiD· 1 shared Dimitris ThanosiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Vassilis G. GorgoulisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immune cell senescence drives responsiveness to immunotherapy in melanoma

Pavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, Panagiotis Bakouros, Sophia Magkouta, Orestis A. Ntintas, Dimitris Veroutis, Giorgos Theocharous, Ioannis V. Kostopoulos, Dimitris-Foivos Thanos, Eftychia Chatziioannou, Ioanna A. Anastasiou, Nefeli Lаgopati, Dimitrios Valakos, Dimitrios Skaltsas, , Vassilis G. Gorgoulis

The paper investigates immune cell senescence in melanoma patients and finds that non-responders to immunotherapy have higher senescence in immune cells compared to responders.

Molecular Cancer · Dec 10, 2025Peer-reviewedImmunology

A Machine Learning approach for assessing drug development risk

Vangelis Vergetis, Gerasimos Liaropoulos, Maria Georganaki, Andreas Dimakakos, Dimitrios Skaltsas, Vassilis G. Gorgoulis, Aristotelis Tsirigos

This paper proposes a machine learning approach to estimate drug development risk more accurately than traditional models.

bioRxiv · Oct 8, 2020 · PreprintBioinformatics